Management

Clean up of normal function isn’t likely in chronicbronchitis and emphysema. The aim of remedy must therefore be to relieve disability by tackling the actual interrelatedproblems of airways obstruction, recurrent infections,breathlessness, hypoxia and terrible exercise tolerance.Factors frustrating chronic bronchitis, particularly cigarettesmoking, has to be withdrawn.

Airways obstructionConventionally the air passages obstruction of chronic bronchitisand emphysema is regarded as being irreversible.However, a lot of patients show some improvementin lung function with therapy directed at relaxingbronchial easy muscle and, although compact, this improvementcan have an important effect on the disabilityof these patients. Treatment in patients who act in response wellto bronchodilators is considerably better than for thosewith fully fixed obstruction.

The most importantbronchodilator real estate agents are the selective pYadrenergicagonists (e.gary. salbutamol and terbutaline), which are bestadministered by breathing. For some patients maximalbronchodilatation requires a substantial drug dose and may bebest employed by nebulizer (e.g. salbutamol A pair of.5-5 mg).Inhaled atropine analogues (ipratropium and oxitropium)is a good idea but, provided optimum dosage amounts of(32 agonists are applied, confer little additionalbenefit.

Oral theophyllines easily obtainable in slow-release formulationare of marginal use in constant bronchitis and emphysema.It had been stated that theophylline improved respiratorymuscle contractility, but next studies did notconfirm this influence.Patients with severe air tract obstruction should havea therapeutic test of steroids – one example is oral prednisolone(30 mg daily) for a period of 2-3 weeks ( blank ) providedthere are no contraindications. For sufferers in whom oralsteroids pose problems (e.g. diabetes) a time period of highdoseinhaled steroid is appropriate.